Balchem Corporation(BCPC)Earnings, Financials & Key Ratios

BCPC•NASDAQ

$161.38

$5.17B mkt cap·34.0× P/E·Price updated May 6, 2026

SectorBasic Materials IndustrySpecialty Chemicals Sub-IndustryIngredients, pigments and specialty minerals

AboutBalchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.Show more

Revenue$1.04B+8.8%
EBITDA$264M+14.1%
Net Income$155M+20.5%
EPS (Diluted)4.75+20.9%
Gross Margin35.74%+1.4%
EBITDA Margin25.41%+5.0%
Operating Margin21.05%+9.8%
Net Margin14.93%+10.8%
ROE12.86%+10.3%
ROIC12.21%+16.9%
Debt/Equity0.15-15.6%
Interest Coverage20.48+85.0%

Technical→

BCPC Key Insights

Balchem Corporation (BCPC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 9/9
✓FCF machine: 16.7% free cash flow margin
✓11 consecutive years of dividend growth
✓High quality earnings: Operating CF exceeds net income
✓Healthy 5Y average net margin of 12.7%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

BCPC Price & Volume

Balchem Corporation (BCPC) stock price & volume — 10-year historical chart

Loading chart...

BCPC Growth Metrics

Balchem Corporation (BCPC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years6.5%

5 Years8.07%

3 Years3.25%

TTM9.62%

Profit CAGR

10 Years10%

5 Years12.84%

3 Years13.69%

TTM15.77%

EPS CAGR

10 Years9.65%

5 Years12.81%

3 Years13.48%

TTM16.79%

Return on Capital

10 Years11.73%

5 Years12.37%

3 Years12.81%

Last Year14.81%

BCPC Recent Earnings

Balchem Corporation (BCPC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)

Q1 2026Latest

Feb 20, 2026

EPS

$1.31

Est $1.29

+1.6%

Revenue

$264M

Est $260M

+1.6%

Q4 2025

Oct 21, 2025

EPS

$1.35

Est $1.36

-0.7%

Revenue

$268M

Est $260M

+3.1%

Q3 2025

Jul 31, 2025

EPS

$1.27

Est $1.25

+1.6%

Revenue

$255M

Est $258M

-0.8%

Q2 2025

Apr 24, 2025

EPS

$1.22

Est $1.25

-2.4%

Revenue

$251M

Est $246M

+2.0%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 20, 2026	$1.31vs $1.29+1.6%	$264Mvs $260M+1.6%
Q4 2025	Oct 21, 2025	$1.35vs $1.36-0.7%	$268Mvs $260M+3.1%
Q3 2025	Jul 31, 2025	$1.27vs $1.25+1.6%	$255Mvs $258M-0.8%
Q2 2025	Apr 24, 2025	$1.22vs $1.25-2.4%	$251Mvs $246M+2.0%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
INGRIngredion IncorporatedDirect Competitor	6.75B	107.13	9.58	-2.84%	10.1%	17.14%	7.56%	0.41
IFFInternational Flavors & Fragrances Inc.Direct Competitor	18.08B	70.77	-48.47	-5.17%	7.78%	5.88%	1.42%	0.47
AVNTAvient CorporationDirect Competitor	3.41B	37.15	41.74	0.61%	2.51%	3.46%	5.72%	0.81
HWKNHawkins, Inc.Direct Competitor	3.46B	167.00	41.44	6.01%	7.75%	15.88%	2.02%	0.35
IOSPInnospec Inc.Direct Competitor	1.94B	78.20	16.74	-3.65%	6.56%	8.23%	4.54%	0.06
MGPIMGP Ingredients, Inc.Direct Competitor	427M	19.98	-4.00	-23.77%	-45.97%	-32.05%	17.81%	0.37
TRMKTrustmark CorporationProduct Competitor	2.64B	44.76	12.10	34.75%	20.01%	10.77%	8.8%	0.53
ADUSAddus HomeCare CorporationProduct Competitor	1.84B	98.44	18.89	23.21%	6.89%	9.34%	5.66%	0.19

Compare BCPC vs Peers

Balchem Corporation (BCPC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs INGR

Most directly comparable listed peer for BCPC.

Scale Benchmark

vs CTVA

Larger-name benchmark to compare BCPC against a more recognizable public peer.

Peer Set

Compare Top 5

vs INGR, IFF, AVNT, HWKN

BCPC Income Statement

Balchem Corporation (BCPC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	594.79M	643.68M	643.71M	703.64M	799.02M	942.36M	922.44M	953.68M	1.04B	1.06B
Revenue Growth %	7.52%	8.22%	0%	9.31%	13.55%	17.94%	-2.11%	3.39%	8.75%	9.62%
Cost of Goods Sold	405.78M	439.43M	432.34M	479.75M	555.85M	661.91M	620.38M	617.48M	666.53M	673.8M
COGS % of Revenue	68.22%	68.27%	67.16%	68.18%	69.57%	70.24%	67.25%	64.75%	64.26%	-
Gross Profit	189.01M▲ 0%	204.25M▲ 8.1%	211.37M▲ 3.5%	223.9M▲ 5.9%	243.17M▲ 8.6%	280.45M▲ 15.3%	302.06M▲ 7.7%	336.21M▲ 11.3%	370.63M▲ 10.2%	383.55M▲ 0%
Gross Margin %	31.78%	31.73%	32.84%	31.82%	30.43%	29.76%	32.75%	35.25%	35.74%	36.27%
Gross Profit Growth %	4.51%	8.06%	3.48%	5.93%	8.61%	15.33%	7.7%	11.31%	10.24%	-
Operating Expenses	91.75M	96.5M	108.81M	112.75M	115.67M	135.26M	142.86M	153.3M	152.3M	161.83M
OpEx % of Revenue	15.43%	14.99%	16.9%	16.02%	14.48%	14.35%	15.49%	16.07%	14.68%	-
Selling, General & Admin	82.45M	84.91M	97.44M	102.42M	102.15M	123.07M	130.13M	136.5M	142.8M	150.37M
SG&A % of Revenue	13.86%	13.19%	15.14%	14.56%	12.78%	13.06%	14.11%	14.31%	13.77%	-
Research & Development	9.3M	11.59M	11.38M	10.33M	13.52M	12.19M	15.05M	16.79M	18.51M	24.92M
R&D % of Revenue	1.56%	1.8%	1.77%	1.47%	1.69%	1.29%	1.63%	1.76%	1.78%	-
Other Operating Expenses	0	0	0	0	0	0	-2.32M	0	-9.01M	-362K
Operating Income	96.9M▲ 0%	107.1M▲ 10.5%	102.55M▼ 4.2%	111.15M▲ 8.4%	127.5M▲ 14.7%	145.19M▲ 13.9%	159.19M▲ 9.6%	182.91M▲ 14.9%	218.33M▲ 19.4%	221.72M▲ 0%
Operating Margin %	16.29%	16.64%	15.93%	15.8%	15.96%	15.41%	17.26%	19.18%	21.05%	20.97%
Operating Income Growth %	6.68%	10.52%	-4.25%	8.38%	14.71%	13.87%	9.65%	14.9%	19.37%	-
EBITDA	141.28M	151.77M	148.41M	162.43M	176.38M	197.03M	214.13M	230.88M	263.52M	266.76M
EBITDA Margin %	23.75%	23.58%	23.06%	23.08%	22.07%	20.91%	23.21%	24.21%	25.41%	25.23%
EBITDA Growth %	3.1%	7.42%	-2.21%	9.44%	8.59%	11.71%	8.68%	7.82%	14.14%	12.29%
D&A (Non-Cash Add-back)	44.38M	44.67M	45.86M	51.28M	48.88M	51.85M	54.94M	47.97M	45.19M	45.04M
EBIT	96.02M	106.64M	102.44M	110.86M	127.69M	144.02M	159.87M	182.98M	209.25M	158.38M
Net Interest Income	-7.53M	-7.61M	-5.96M	-4.44M	-2.46M	-10.27M	-22.61M	-16.53M	-10.22M	-7.29M
Interest Income	12K	0	0	0	0	0	0	0	0	0
Interest Expense	7.54M	7.61M	5.96M	4.44M	2.46M	10.27M	22.61M	16.53M	10.22M	10.4M
Other Income/Expense	-8.41M	-8.07M	-6.08M	-4.73M	-2.27M	-11.44M	-21.93M	-16.46M	-19.3M	-18.1M
Pretax Income	88.49M▲ 0%	99.03M▲ 11.9%	96.48M▼ 2.6%	106.42M▲ 10.3%	125.23M▲ 17.7%	133.75M▲ 6.8%	137.26M▲ 2.6%	166.45M▲ 21.3%	199.03M▲ 19.6%	203.61M▲ 0%
Pretax Margin %	14.88%	15.38%	14.99%	15.12%	15.67%	14.19%	14.88%	17.45%	19.19%	19.26%
Income Tax	-1.58M	20.46M	16.81M	21.79M	29.13M	28.38M	28.72M	37.98M	44.19M	45.53M
Effective Tax Rate %	-1.79%	20.66%	17.42%	20.48%	23.26%	21.22%	20.92%	22.82%	22.2%	22.36%
Net Income	90.07M▲ 0%	78.57M▼ 12.8%	79.67M▲ 1.4%	84.62M▲ 6.2%	96.1M▲ 13.6%	105.37M▲ 9.6%	108.54M▲ 3.0%	128.47M▲ 18.4%	154.84M▲ 20.5%	158.08M▲ 0%
Net Margin %	15.14%	12.21%	12.38%	12.03%	12.03%	11.18%	11.77%	13.47%	14.93%	14.95%
Net Income Growth %	60.92%	-12.77%	1.4%	6.22%	13.57%	9.64%	3.01%	18.36%	20.53%	15.77%
Net Income (Continuing)	90.07M	78.57M	79.67M	84.62M	96.1M	105.37M	108.54M	128.47M	154.84M	158.08M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	2.79▲ 0%	2.42▼ 13.3%	2.45▲ 1.2%	2.60▲ 6.1%	2.94▲ 13.1%	3.25▲ 10.5%	3.35▲ 3.1%	3.93▲ 17.3%	4.75▲ 20.9%	4.90▲ 0%
EPS Growth %	59.43%	-13.26%	1.24%	6.12%	13.08%	10.54%	3.08%	17.31%	20.87%	16.79%
EPS (Basic)	2.81	2.44	2.48	2.63	2.98	3.29	3.38	3.97	4.80	-
Diluted Shares Outstanding	32.23M	32.45M	32.51M	32.5M	32.67M	32.39M	32.45M	32.72M	32.6M	32.28M
Basic Shares Outstanding	32.02M	32.26M	32.14M	32.18M	32.22M	32.02M	32.11M	32.33M	32.6M	32.28M
Dividend Payout Ratio	13.4%	17.09%	19%	19.74%	19.48%	19.66%	21.07%	19.91%	18.27%	-

BCPC Balance Sheet

Balchem Corporation (BCPC) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	199.34M	226.31M	254.95M	266.89M	322.23M	335.8M	314.24M	313.77M	365.61M	388.94M
Cash & Short-Term Investments	40.42M	54.27M	65.67M	84.57M	103.24M	66.56M	64.45M	49.52M	74.57M	72.87M
Cash Only	40.42M	54.27M	65.67M	84.57M	103.24M	66.56M	64.45M	49.52M	74.57M	72.87M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	91.23M	99.55M	93.44M	98.21M	117.41M	131.58M	125.28M	119.66M	143.6M	154.23M
Days Sales Outstanding	55.98	56.45	52.99	50.95	53.63	50.96	49.57	45.8	50.53	48.79
Inventory	60.7M	67.19M	83.89M	70.62M	91.06M	119.67M	109.52M	130.8M	131.45M	146.74M
Days Inventory Outstanding	54.6	55.81	70.83	53.73	59.79	65.99	64.44	77.32	71.98	75.67
Other Current Assets	2.22M	1.48M	7.55M	3.44M	4.41M	13.09M	7.19M	5.74M	16M	15.09M
Total Non-Current Assets	764.3M	755.04M	900.74M	898.96M	877.09M	1.29B	1.28B	1.26B	1.34B	1.3B
Property, Plant & Equipment	189.79M	194.34M	224.2M	236.51M	246.81M	290.79M	295.9M	299.2M	322.84M	318.2M
Fixed Asset Turnover	3.13x	3.31x	2.87x	2.98x	3.24x	3.24x	3.12x	3.19x	3.21x	3.35x
Goodwill	441.36M	448M	524M	529.46M	523.95M	769.51M	778.91M	780.03M	816.38M	811.45M
Intangible Assets	128.07M	105.98M	143.92M	121.66M	94.67M	213.29M	191.21M	165.05M	163.29M	156.46M
Long-Term Investments	4.8M	4.9M	-56.43M	-51.36M	-46.45M	4.29M	4.08M	3.86M	3.72M	7.43M
Other Non-Current Assets	-48.28M	-42.49M	8.62M	11.33M	11.67M	-51.96M	12.87M	13.46M	14.42M	65.19M
Total Assets	963.64M▲ 0%	981.36M▲ 1.8%	1.16B▲ 17.8%	1.17B▲ 0.9%	1.2B▲ 2.9%	1.62B▲ 35.5%	1.6B▼ 1.7%	1.58B▼ 1.4%	1.71B▲ 8.4%	1.69B▲ 0%
Asset Turnover	0.62x	0.66x	0.56x	0.60x	0.67x	0.58x	0.58x	0.61x	0.61x	0.63x
Asset Growth %	1.58%	1.84%	17.76%	0.88%	2.87%	35.45%	-1.68%	-1.37%	8.39%	23.67%
Total Current Liabilities	108.4M	82.06M	92.26M	94.43M	143.8M	140.04M	148.49M	157.69M	176.38M	152.54M
Accounts Payable	28.45M	33.79M	37.27M	23.74M	56.24M	57.32M	55.5M	54.74M	60.42M	0
Days Payables Outstanding	25.59	28.07	31.46	18.06	36.93	31.61	32.66	32.36	33.09	23.74
Short-Term Debt	35M	0	0	0	0	0	0	0	3.82M	33.71M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	13.85M	2.26M	41.46M	48.6M	65.63M	62.15M	71.54M	22.89M	77.18M	118.83M
Current Ratio	1.84x	2.76x	2.76x	2.83x	2.24x	2.40x	2.12x	1.99x	2.07x	2.07x
Quick Ratio	1.28x	1.94x	1.85x	2.08x	1.61x	1.54x	1.38x	1.16x	1.33x	1.33x
Cash Conversion Cycle	84.99	84.19	92.35	86.61	76.49	85.34	81.35	90.76	89.43	100.73
Total Non-Current Liabilities	238.36M	207.68M	319.76M	243.18M	178.51M	546.19M	394.74M	267.77M	273.76M	256.09M
Long-Term Debt	183.96M	156M	248.57M	163.57M	108.57M	440.57M	309.57M	190M	175.32M	33.71M
Capital Lease Obligations	0	0	4.83M	6.08M	7.11M	16.02M	16.54M	14.72M	12.87M	40.53M
Deferred Tax Liabilities	48.55M	44.31M	56.43M	51.36M	46.45M	62.78M	52.05M	43.72M	75.45M	224.2M
Other Non-Current Liabilities	5.85M	7.37M	9.93M	22.18M	16.37M	26.81M	16.58M	19.34M	10.12M	221.08M
Total Liabilities	346.75M	289.74M	412.01M	337.61M	322.31M	686.23M	543.23M	425.46M	450.15M	408.63M
Total Debt	218.96M	156M	255.87M	171.99M	118.04M	460.61M	330.33M	208.04M	192.01M	33.71M
Net Debt	178.55M	101.73M	190.2M	87.41M	14.8M	394.05M	265.89M	158.53M	117.44M	-39.16M
Debt / Equity	0.35x	0.23x	0.34x	0.21x	0.13x	0.49x	0.31x	0.18x	0.15x	0.15x
Debt / EBITDA	1.55x	1.03x	1.72x	1.06x	0.67x	2.34x	1.54x	0.90x	0.73x	0.13x
Net Debt / EBITDA	1.26x	0.67x	1.28x	0.54x	0.08x	2.00x	1.24x	0.69x	0.45x	0.45x
Interest Coverage	12.73x	14.01x	17.19x	24.97x	51.99x	14.03x	7.07x	11.07x	20.48x	15.23x
Total Equity	616.88M▲ 0%	691.62M▲ 12.1%	743.67M▲ 7.5%	828.23M▲ 11.4%	877.01M▲ 5.9%	938.28M▲ 7.0%	1.05B▲ 12.3%	1.15B▲ 9.1%	1.26B▲ 9.3%	1.29B▲ 0%
Equity Growth %	18.4%	12.12%	7.53%	11.37%	5.89%	6.99%	12.33%	9.1%	9.35%	39.9%
Book Value per Share	19.14	21.32	22.88	25.48	26.84	28.97	32.48	35.15	38.57	39.81
Total Shareholders' Equity	616.88M	691.62M	743.67M	828.23M	877.01M	938.28M	1.05B	1.15B	1.26B	1.29B
Common Stock	2.13M	2.15M	2.16M	2.16M	2.15M	2.15M	2.15M	2.17M	2.14M	2.14M
Retained Earnings	464.64M	528.03M	590.92M	656.74M	732.14M	814.49M	897.49M	997.49M	1.12B	1.16B
Treasury Stock	0	-56K	-18.07M	-7.87M	0	0	0	0	0	0
Accumulated OCI	-1.64M	-3.6M	-5.56M	4.17M	-4.99M	-7.15M	8.69M	-23.75M	41.55M	31.75M
Minority Interest	0	0	0	0	0	0	0	0	0	0

BCPC Cash Flow Statement

Balchem Corporation (BCPC) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	110.62M	118.7M	124.46M	150.49M	160.51M	138.54M	183.76M	182M	216.56M	216.56M
Operating CF Margin %	18.6%	18.44%	19.34%	21.39%	20.09%	14.7%	19.92%	19.08%	20.88%	-
Operating CF Growth %	2.79%	7.3%	4.86%	20.92%	6.66%	-13.69%	32.64%	-0.96%	18.99%	71.32%
Net Income	90.07M	78.57M	79.67M	84.62M	96.1M	105.37M	108.54M	128.47M	154.84M	158.08M
Depreciation & Amortization	44.38M	44.67M	45.86M	51.28M	48.88M	51.85M	54.94M	47.97M	45.69M	47.17M
Stock-Based Compensation	6.26M	6.41M	7.6M	8.3M	10.8M	13.22M	16.05M	16.68M	18.06M	19.6M
Deferred Taxes	-28.78M	-5.4M	-3.56M	-4.63M	-5.94M	-8.36M	-10.81M	-6.78M	6.26M	115K
Other Non-Cash Items	663K	-1.54M	-146K	2.38M	-257K	1.68M	-4.96M	1.77M	-835K	-20.12M
Working Capital Changes	-1.98M	-4.01M	-4.96M	8.53M	10.93M	-25.22M	20.01M	-6.12M	-7.46M	15.31M
Change in Receivables	-3.91M	-7.77M	11.62M	-3.6M	-20.7M	-3.62M	6.97M	5.58M	-20.85M	10.07M
Change in Inventory	-319K	-6.02M	-11.4M	13.92M	-21.02M	-7.8M	10.53M	-22.79M	3.63M	12.9M
Change in Payables	1.51M	5.99M	1.13M	-3.85M	46.19M	-15.54M	3.55M	9.06M	11.29M	737K
Cash from Investing	-42.7M	-31.99M	-156.22M	-34.59M	-35.3M	-416.01M	-34.81M	-59.74M	-43.89M	-44.27M
Capital Expenditures	-28.09M	-19.72M	-28.41M	-33.83M	-37.45M	-50.29M	-37.89M	-35.66M	-43.49M	5.56M
CapEx % of Revenue	4.72%	3.06%	4.41%	4.81%	4.69%	5.34%	4.11%	3.74%	4.19%	-
Acquisitions	-17.39M	-17.4M	-141.06M	87K	318K	-365.78M	-1.54M	-24.16M	-49K	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	2.79M	5.13M	13.25M	-850K	1.83M	56K	1.88M	89K	0	-49.86M
Cash from Financing	-68.63M	-71.45M	43.38M	-101.16M	-102.18M	246.68M	-153.32M	-133.81M	-152.81M	-155.62M
Debt Issued (Net)	-64.38M	-63.52M	75M	-85.15M	-55.16M	300.83M	-131.22M	-119.78M	-26.19M	1K
Equity Issued (Net)	-1.91M	-1.39M	-21.32M	-13.46M	-35.24M	-35.42M	-4.47M	-5.68M	-98.33M	-102.31M
Dividends Paid	-12.07M	-13.43M	-15.13M	-16.7M	-18.72M	-20.71M	-22.87M	-25.58M	-28.29M	-30.79M
Share Repurchases	-1.91M	-1.39M	-21.32M	-13.46M	-35.24M	-35.42M	-4.47M	-5.68M	-107.64M	-118M
Other Financing	9.73M	6.9M	4.84M	14.15M	6.94M	1.98M	5.24M	17.23M	0	-22.57M
Net Change in Cash	1.77M▲ 0%	13.85M▲ 681.3%	11.4M▼ 17.7%	18.9M▲ 65.7%	18.67M▼ 1.2%	-36.68M▼ 296.5%	-2.11M▲ 94.2%	-14.93M▼ 606.7%	25.05M▲ 267.8%	22.97M▲ 0%
Free Cash Flow	82.52M▲ 0%	98.97M▲ 19.9%	96.05M▼ 3.0%	116.67M▲ 21.5%	123.06M▲ 5.5%	88.25M▼ 28.3%	145.87M▲ 65.3%	146.34M▲ 0.3%	173.07M▲ 18.3%	182.23M▲ 0%
FCF Margin %	13.87%	15.38%	14.92%	16.58%	15.4%	9.36%	15.81%	15.34%	16.69%	17.23%
FCF Growth %	-1.31%	19.93%	-2.96%	21.47%	5.48%	-28.29%	65.3%	0.32%	18.27%	20.88%
FCF per Share	2.56	3.05	2.95	3.59	3.77	2.72	4.50	4.47	5.31	5.31
FCF Conversion (FCF/Net Income)	1.23x	1.51x	1.56x	1.78x	1.67x	1.31x	1.69x	1.42x	1.40x	1.15x
Interest Paid	7.02M	6.94M	0	4.67M	4.55M	11.88M	25.93M	17.7M	10.6M	7.59M
Taxes Paid	25.84M	20.59M	0	22.64M	25.36M	33.02M	35.73M	42.64M	37.75M	36.31M

BCPC Key Ratios

Balchem Corporation (BCPC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	15.83%	12.01%	11.1%	10.77%	11.27%	11.61%	10.9%	11.66%	12.86%	12.38%
Return on Invested Capital (ROIC)	9.33%	10.11%	8.91%	9.01%	10.58%	9.79%	9%	10.44%	12.21%	12.21%
Gross Margin	31.78%	31.73%	32.84%	31.82%	30.43%	29.76%	32.75%	35.25%	35.74%	36.27%
Net Margin	15.14%	12.21%	12.38%	12.03%	12.03%	11.18%	11.77%	13.47%	14.93%	14.95%
Debt / Equity	0.35x	0.23x	0.34x	0.21x	0.13x	0.49x	0.31x	0.18x	0.15x	0.15x
Interest Coverage	12.73x	14.01x	17.19x	24.97x	51.99x	14.03x	7.07x	11.07x	20.48x	15.23x
FCF Conversion	1.23x	1.51x	1.56x	1.78x	1.67x	1.31x	1.69x	1.42x	1.40x	1.15x
Revenue Growth	7.52%	8.22%	0%	9.31%	13.55%	17.94%	-2.11%	3.39%	8.75%	9.62%

BCPC SEC Filings & Documents

Balchem Corporation (BCPC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 30, 2026·SEC

Material company update

Feb 20, 2026·SEC

Material company update

Feb 19, 2026·SEC

10-K Annual Reports

FY 2026

Feb 20, 2026·SEC

FY 2025

Feb 21, 2025·SEC

FY 2024

Feb 16, 2024·SEC

10-Q Quarterly Reports

FY 2026

Apr 30, 2026·SEC

FY 2025

Oct 21, 2025·SEC

FY 2025

Jul 31, 2025·SEC

BCPC Frequently Asked Questions

Balchem Corporation (BCPC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Balchem Corporation (BCPC) reported $1.06B in revenue for fiscal year 2025. This represents a 3905% increase from $26.4M in 1996.

Balchem Corporation (BCPC) grew revenue by 8.8% over the past year. This is steady growth.

Yes, Balchem Corporation (BCPC) is profitable, generating $158.1M in net income for fiscal year 2025 (14.9% net margin).

Dividend & Returns

Yes, Balchem Corporation (BCPC) pays a dividend with a yield of 0.54%. This makes it attractive for income-focused investors.

Balchem Corporation (BCPC) has a return on equity (ROE) of 12.9%. This is reasonable for most industries.

Balchem Corporation (BCPC) generated $182.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More BCPC

Balchem Corporation (BCPC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Balchem Corporation(BCPC)Earnings, Financials & Key Ratios

BCPC Key Insights

✓Strengths

✗Weaknesses

BCPC Price & Volume

BCPC Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

BCPC Recent Earnings

BCPC Peer Comparison

Compare BCPC vs Peers

vs INGR

vs CTVA

Compare Top 5

BCPC Income Statement

BCPC Balance Sheet

BCPC Cash Flow Statement

BCPC Key Ratios

BCPC SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

BCPC Frequently Asked Questions

Explore More BCPC

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation